Share

Comments on:

Merck settles investor suits on cholesterol drugs

Back to the article » |
TRENTON, N.J. (AP) — Merck & Co. has agreed to pay $688 million to settle two long-running lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop in sales. Merck, the world's third biggest drugmaker by revenue, said Thursday that it agreed to the settlement because it's in the best interest of the company and...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.